ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,251.33
      1.27%
      Dow Jones
      40,421.36
      0.33%
      Brent Oil
      81.64
      0.15%
      Bitcoin
      67,395.05
      -0.31%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Neuropace Inc (NPCE)

      7. Neuropace Inc (NPCE) Financials

      Neuropace Inc

      Neuropace Inc (NPCE)

      NASDAQ
      7.63
      -0.33
      (-4.15%)
      Closed July 23 4:00PM
      Delayed by 15 minutes
      7.63
      0.00
      (0.00%)
      After Hours: 3:50PM
      Delayed by 15 minutes

      Neuropace Inc Financial Summary

      The current NPCE market cap is 219.5M. The company's latest EPS is USD -1.1456 and P/E is -6.66.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 14.47M16.51M16.43M18.01M18.12M
      Operating Income -8.32M-7.85M-5.95M-5.05M-7.55M
      Net Income -10.38M-9.12M-7.26M-6.2M-8.93M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 36.97M41.14M45.18M45.52M65.42M
      Operating Income -22.03M-13.05M-23.74M-40.79M-27.17M
      Net Income -29.97M-24.28M-36.08M-47.08M-32.96M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 106.27M102.23M99.3M107.65M98.85M
      Total Liabilities 78.78M81.01M82.94M87M84.51M
      Total Equity 27.49M21.23M16.36M20.65M14.34M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 21.1M55.95M133.56M114.11M107.65M
      Total Liabilities 76.88M62.36M60.06M79.33M87M
      Total Equity -129.35M-147.83M73.5M34.78M20.65M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -9.7M-14.06M-16.36M-19.7M-7.53M
      Investing 10.07M15.37M19.56M23.03M2.4M
      Financing -255k-60k-87k8.13M72k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -25.03M-21.61M-24.58M-36.87M-19.7M
      Investing 3.62M-10.77M-85.4M23.8M23.03M
      Financing 21.37M55.01M102.53M490k8.13M

      Stats and Ratios

      Market Cap 219.5M
      Price to Earnings Ratio -6.66
      Price to Sales Ratio 3.36
      Price to Cash Ratio 12.16
      Price to Book Ratio 10.63
      Dividend Yield -

      Share Statistics

      Shares Outstanding 28.77M
      Average Volume (1 week) 75.76k
      Average Volume (1 Month) 170.64k
      52 Week Change 82.54%
      52 Week High 18.15
      52 Week Low 3.91
      Spread (Intraday) 0.2 (2.58%)

      Company Info

      Company Name Neuropace Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.neuropace.com
      Industry surgical,med instr,apparatus (3841)